PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1070241
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1070241
Global Creatinine Assay Kits Market is valued approximately USD 236.52 million in 2021 and is anticipated to grow with a healthy growth rate of more than 5.3% over the forecast period 2022-2028.
Creatinine assay kits are the type of assay kit, used for assessing creatinine in biological samples without the requirement for any pre-treatment. These kits help in measuring the level of creatinine in the urine, plasma/serum, and other biological fluids to examine the condition of the kidney. The rising awareness and adoption of preventive healthcare, the growing prevalence of kidney or renal disorders, coupled with the incidences of other chronic diseases that affect renal function are the primary factors that are stimulating the market demand across the globe. As per the National Kidney Foundation, there were 10% of the population around the world is suffering from chronic kidney disease (CKD), and millions of people die every year. Moreover, the availability of favorable government initiatives to promote renal health, rising developments in biomedical research, as well as increasing geriatric population worldwide is further accelerating the market growth in the approaching period. For instance, as per the United Nations, The Department of Economic and Social Affair, in 2019, there were nearly 703 million persons aged 65 years or above globally. Also, the number of older persons is likely to get double to 1.5 billion by 2050. Therefore, the increasing aged population is propelling the demand for the creatinine assay kits as this age group is more likely to suffer from various chronic illnesses and renal disease, thus, in turn, fueling the market growth. However, limited usage of creatinine assay kits in IVD and frequently changing regulatory policies impede the growth of the market over the forecast period of 2022-2028. Also, high growth potential in emerging economies and increasing investments for R&D activities are anticipated to act as a catalyzing factor for the market demand during the forecast period.
The key regions considered for the global Creatinine Assay Kits market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the rising awareness towards preventive healthcare, increasing R&D activities, and presence of the leading market players. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the escalating geriatric population, growing prevalence of chronic kidney disease (CKD), as well as the development of healthcare infrastructure, would create lucrative growth prospects for the Creatinine Assay Kits market across the Asia-Pacific region.
Major market players included in this report are:
Thermo Fisher Scientific Inc.
Merck Group
Abbott Laboratories Inc.
Abcam PLC
Quidel Corporation
Enzo Life Sciences Inc.
Cayman Chemical Company
Cell Biolabs Inc.
Tulip Diagnostics Pvt. Ltd.
Arbor Assays Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type
Jaffe's Kinetic Test Kits
Creatinine-PAP Test Kits
ELISA Test Kits
By Type of Sample
Blood/Serum
Urine
Other Samples
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Creatinine Assay Kits Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
List of figures